BIOCURE BioTech Raises Tens of Millions of Yuan in Pre-A+ Funding Round

11 hour ago / Read about 0 minute

Author：小编

Recently, Jiangsu BIOCURE BioTech Co., Ltd. successfully secured tens of millions of yuan in a Pre-A+ funding round, with exclusive investment from Lanbridge Capital. This achievement represents the company's fourth round of financing in just three years. The capital market's endorsement not only underscores the company's robust research and development (R&D) capabilities and promising commercialization outlook but also injects fresh momentum into the advancement of the high-end medical device sector. Building on its proprietary EDP technology platform, BIOCURE BioTech has made significant technological strides in the realm of high-end implantable medical devices, successfully bringing several products to market.

Previous page：A-Shares Witness Midday Surge: Photovoltaic and Li...

Next page：Hainan Aerospace Launch Technology Company, a Subs...

Return to List

Hot Reading

1 day ago

After outages, Amazon to make senior engineers sign off on AI-assisted changes

2 day ago

Ring’s Jamie Siminoff has been trying to calm privacy fears since the Super Bowl, but his answers may not help

2 day ago

Anthropic sues Defense Department over supply chain risk designation

2 day ago

Qualcomm’s partnership with Neura Robotics is just the beginning